title: Aggressive meningeal tumors: review of a series.
abstract: A series of 25 patients with aggressive meningeal tumors was studied to determine the efficacy of various management options. The median age of the patients was 52 years, with a range of 13 to 73 years. A marked male preponderance (64%) was noted. Twenty of 25 patients experienced recurrence during a median follow-up time of 47 months. Survival and freedom from recurrence varied with histological diagnosis. Recurrence was noted sooner in patients who had received partial resections on first presentation of tumor than in those who had received total resections at first presentation. Survival time was also shorter for patients who underwent partial resections at first presentation than for patients who underwent total resections. Patients' prognoses did not improve as a result of either chemotherapy or radiotherapy. Of six patients with extracranial metastases, the median time to metastasis was 102 months, with a 5-year metastasis-free rate of 85%. The most common sites of metastasis in these six patients were lung and bone. In each tumor type, histological features used in diagnosis and radiological features studied from computerized tomography and magnetic resonance imaging were evaluated, compared, and discussed. Of eight patients studied with an in vivo bromodeoxyuridine (BUdR) labeling index (LI), seven showed an LI of 1% or more. The authors support the incorporation of the BUdR LI into the diagnostic process to provide a better estimate of the potential for tumor recurrence.
authors: Department of Neurosurgery, University of Texas M. D. Anderson Cancer Center, Houston.
authors: G A
authors: GA
authors: Younis
authors: R
authors: R
authors: Sawaya
authors: F
authors: F
authors: DeMonte
authors: K R
authors: KR
authors: Hess
authors: S
authors: S
authors: Albrecht
authors: J M
authors: JM
authors: Bruner
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006393:Hemangiopericytoma / Q000000981:diagnostic imaging / Q000473:pathology / Q000556:secondary / Q000628:therapy; D006801:Humans; D008297:Male; D008577:Meningeal Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy; D008579:Meningioma / Q000000981:diagnostic imaging / Q000473:pathology / Q000556:secondary / Q000628:therapy; D008875:Middle Aged; D011859:Radiography